Effect of a probiotic preparation on gut microbiota in critically ill septic patients admitted to intensive care unit: A pilot randomized controlled trial

Q4 Pharmacology, Toxicology and Pharmaceutics
A. Mahmoodpoor, Roya Ghaemi, Kamran Shadvar, S. Saghaleini, Sama Rahnemayan, Ali Shamekh, S. Sanaie
{"title":"Effect of a probiotic preparation on gut microbiota in critically ill septic patients admitted to intensive care unit: A pilot randomized controlled trial","authors":"A. Mahmoodpoor, Roya Ghaemi, Kamran Shadvar, S. Saghaleini, Sama Rahnemayan, Ali Shamekh, S. Sanaie","doi":"10.34172/ps.2022.20","DOIUrl":null,"url":null,"abstract":"Background: Sepsis promotes severe physiologic alterations in patients, and it has been reported to induce profound changes in the gut microbial composition. The decrease of 'health ‑benefiting' microbes and the increase in dysbiosis in critically ill patients are thought to induce or aggravate sepsis. In this study, we aimed to explore the effect of a probiotic preparation, Lactocare®, on gut microbiota in critically ill septic patients admitted to the intensive care unit (ICU). Methods: Forty critically ill patients diagnosed with sepsis were assessed in this pilot randomized controlled trial. Patients were randomized into two groups: Lactocare and control groups. Patients in the Lactocare group received two capsules of Lactocare® for 10 days. Fecal samples were taken from all patients on days 1 and 10 for determining the gut microbial pattern. The primary outcome was gut microbial flora, and secondary outcomes were intensive care unit (ICU) length of stay and mortality. Results: Intragroup changes showed that all microbial flora considerably changed during the study period; the number of microbial flora significantly decreased in the control group and increased in the Lactocare group. Patients in the Lactocare group had a significantly lower incidence of diarrhea and infection with multidrug-resistant organisms. There was no difference in ICU length of stay in the Lactocare group compared to the control group (p= 0.289). The mortality rate was 30% in the control group compared to 20% in the Lactocare group (p: 0.465). Conclusions: This study showed a remarkable effect of the probiotic preparation on the gut microbiota in critically ill septic patients as it decreased the number of opportunistic pathogens. However, additional clinical research is needed to translate research into clinical practice to refine the clinical indication of the specific probiotic strains.","PeriodicalId":31004,"journal":{"name":"Infarma Pharmaceutical Sciences","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infarma Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/ps.2022.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sepsis promotes severe physiologic alterations in patients, and it has been reported to induce profound changes in the gut microbial composition. The decrease of 'health ‑benefiting' microbes and the increase in dysbiosis in critically ill patients are thought to induce or aggravate sepsis. In this study, we aimed to explore the effect of a probiotic preparation, Lactocare®, on gut microbiota in critically ill septic patients admitted to the intensive care unit (ICU). Methods: Forty critically ill patients diagnosed with sepsis were assessed in this pilot randomized controlled trial. Patients were randomized into two groups: Lactocare and control groups. Patients in the Lactocare group received two capsules of Lactocare® for 10 days. Fecal samples were taken from all patients on days 1 and 10 for determining the gut microbial pattern. The primary outcome was gut microbial flora, and secondary outcomes were intensive care unit (ICU) length of stay and mortality. Results: Intragroup changes showed that all microbial flora considerably changed during the study period; the number of microbial flora significantly decreased in the control group and increased in the Lactocare group. Patients in the Lactocare group had a significantly lower incidence of diarrhea and infection with multidrug-resistant organisms. There was no difference in ICU length of stay in the Lactocare group compared to the control group (p= 0.289). The mortality rate was 30% in the control group compared to 20% in the Lactocare group (p: 0.465). Conclusions: This study showed a remarkable effect of the probiotic preparation on the gut microbiota in critically ill septic patients as it decreased the number of opportunistic pathogens. However, additional clinical research is needed to translate research into clinical practice to refine the clinical indication of the specific probiotic strains.
益生菌制剂对重症化脓症患者肠道菌群的影响:一项随机对照试验
背景:脓毒症促进患者严重的生理改变,据报道,脓毒症会引起肠道微生物组成的深刻变化。在危重病人中,“有益健康”的微生物减少和生态失调增加被认为会诱发或加重败血症。在这项研究中,我们旨在探讨益生菌制剂乳护®对重症监护室(ICU)重症脓毒症患者肠道微生物群的影响。方法:对40例诊断为脓毒症的危重患者进行随机对照试验。患者随机分为两组:乳护组和对照组。乳护理组患者连续10天服用两粒乳护理®胶囊。在第1天和第10天采集所有患者的粪便样本以确定肠道微生物模式。主要结局是肠道微生物菌群,次要结局是重症监护病房(ICU)的住院时间和死亡率。结果:组内变化表明,在研究期间,所有微生物区系都发生了显著变化;对照组微生物菌群数量显著减少,乳糖组微生物菌群数量显著增加。乳护组患者腹泻和多重耐药菌感染的发生率显著降低。与对照组相比,乳护理组的ICU住院时间无差异(p= 0.289)。对照组的死亡率为30%,而乳护理组为20% (p: 0.465)。结论:本研究显示益生菌制剂对脓毒症危重患者肠道菌群有显著影响,可减少条件致病菌的数量。然而,需要更多的临床研究将研究转化为临床实践,以完善特定益生菌菌株的临床适应症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
17
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信